Boehringer Ingelheim Animal Health – Prascend

Boehringer Ingelheim Animal Health commissioned ANIMA RES with the 3D visualisation of the mode of action of Prascend, a pergolide mesylate for horses for the treatment of equine Cushing‘s syndrome (ECS) / pituitary pars intermedia dysfunction (PPID). The mode of action 3D animation film shows how the active substance pergolide mesylate blocks the excessive secretion of ACTH (adrenocorticotropic hormone) in the pituitary gland.

 

Testimonial:

“As an equine brand manager launching a new drug in to an old untended market, Equine Cushing’s Disease, I needed to have something that brought the science of our drug to life for the owner as well as our Veterinary Customers. ANIMA RES was able to provide just what I was looking for, with a collaborative effort between technical teammates and the expertise and flexibility of the ANIMA RES team we produced an outstanding Mode of Action Video that was constantly praised by those who saw it. It was that rare combination of educational with enough entertainment to get people to really watch it. I look forward to working with Pablo and his team at ANIMA RES on my next brand launch!”

Erica Bord, Boehringer Ingelheim Animal Health GmbH Global Marketing
To the website of “Prascend”